Evidence map›Paper›PMID 41611788›Full record

ArticleScientific reports2026

DFT calculation of Ac

Danni Ramdhani, Hiroshi Watabe, Stephen Ahenkorah, Rina F Nuwarda, Ari Hardianto, Regaputra S Janitra

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Danni RamdhaniDepartment of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Jl Ir. Soekarno KM 21, Jatinangor, 45363, Indonesia. d.ramdhani@unpad.ac.id.
Hiroshi WatabeDivision of Radiation Protection and Safety Control, Research Center for Accelerator and Radioisotope Science (RARiS), Tohoku University, Sendai, Japan.
Stephen AhenkorahDepartment of Radiology, The University of Iowa, Iowa City, IA, 52242, USA.
Rina F NuwardaDepartment of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Jl Ir. Soekarno KM 21, Jatinangor, 45363, Indonesia.
Ari HardiantoDepartment of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Jl. Raya Bandung - Sumedang km 21, Jatinangor, 45363, West Java, Indonesia.
Regaputra S JanitraResearch Center for Molecular Biotechnology and Bioinformatics, Universitas Padjadjaran, Bandung, 40132, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The stability constant (logK1) and reactivity are ultimately the most crucial components to consider during the evaluation and selection of chelators to match with a specific radiometal ion for usage in radiopharmaceutical applications. These components evaluate the thermodynamic stability of the radiometal-chelator complex. Additionally, the effectiveness of chelator in binding with radiometal ions with relatively large atomic radii (e.g., 213Bi3+ and 225Ac3+) coupled with charge-diffuse properties result in weaker metal-ligand interactions, and this poses challenges in chelator development. The (2-[(carboxymethyl)]5-(4-nitrophenyl-1-[4,7,10-tris(carboxymethyl)-1,4,7,10-tPentan-2-yl) amino] acetic acid (3p-C-DEPA) is a new hybrid chelator designed for potential radio-complexation applications in radio-theranostics and preclinical data has shown great promise for this chelating ligand. Hence, this study investigates the stability constant and chemical reactivity descriptors of the complex generated between 3p-C-DEPA and the α-emitting radioisotopes 213Bi3+ and 225Ac3+ as well as the β-emitting particle 177Lu3+ for the first-time using density functional theory (DFT) calculations. The method employs two functional densities, MO6-HF and B3LYP, using the basis set 6-311G(d)/SDD, alongside the continuous solvation models SMD (solvation model density) and COSMO (conductor-like screening model). The interactions of all radiometals with the hybrid chelator 3p-C-DEPA are compared to the benchmark chelator, 1,4,7,10-tetrazacyclodecane-1,4,7,10-tetraacetic acid (DOTA), yielding comprehensive data on the stability constants and based structural features of radiometal-chelator complexes. DFT analysis has shown that the stability of the 3p-C-DEPA chelator complex formation is influenced by the atomic radius of the radiometal and the number of nitrogen and oxygen donors, proving to be effective for Ac3+ and Bi3+, in contrast to Lu3+, which shows lower stability constant values.

Indexed as

Alpha ParticlesAmericiumBismuthChelating AgentsCoordination ComplexesRadiopharmaceuticalsDensity Functional TheoryThermodynamicsAmericiumBismuthChelating AgentsCoordination ComplexesRadiopharmaceuticals3p-C-DEPAAlpha-particleDFT calculationHybrid chelatorReactivityStability constant

Identifiers

PMID41611788
PMCPMC12913990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.